Author:
Wu Daochun,Feng Yue,Wang Hua,Yang Junfeng,Chen Xian,Wang Yueping,Cong Lai Christopher,Zhang Yufang,Li Cong,Xia Xueshan,He Yanping
Funder
National Nature Science Foundation of China
National Natural Science Foundation of China
Publisher
Springer Science and Business Media LLC
Subject
Organic Chemistry,General Pharmacology, Toxicology and Pharmaceutics
Reference18 articles.
1. Alexandra A, Peter K (2015) Interferon-based combination treatment for chronic hepatitis C in the era of direct acting antivirals. Ann Gastroenterol 28:55–65
2. Arataki K, Kumada H, Toyota K, Ohishi S, Takahashi S, Tazuma S, Chayama K (2006) Evolution of hepatitis C virus quasispecies during ribavirin and interferon-alpha-2b monotherapy. Intervirology 49:352–361
3. Choo QL, Kuo G, Weiner AJ, Overby LR, Bradley DW (1989) Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome. Science 244:359–362
4. Ding YL, Girardet JL, Smith KL, Larson G, Prigaro B, Wu JZ, Yao NH (2006) Parallel synthesis of 5-cyano-6-aryl-2-thiouracil derivatives as inhibitors for hepatitis C viral NS5B RNA-dependent RNA polymerase. Bioorg Chem 34:26–38
5. Fauvelle C, Lepiller Q, Felmlee DJ, Fofana I, Habersetzer F, Stoll-Keller F, Baumert TF, Fafi-Kremer S (2013) Hepatitis C virus vaccines-progress and perspectives. Microb Pathog 58:66–72
Cited by
3 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献